de Leeuw P W, Birkenhäger W H
Dept. of Medicine, Zuiderziekenhuis, Rotterdam, The Netherlands.
Clin Exp Hypertens A. 1987;9 Suppl 1:281-92. doi: 10.3109/10641968709160179.
In a series of investigations we have evaluated efferent renal nerve activity in hypertensive man. Net renal release of noradrenaline, calculated as the arterio-venous gradient for noradrenaline across the kidney times flow, was taken as an index of local adrenergic activity. Renal blood flow, under various circumstances, was determined by xenon-washout. At rest noradrenaline release was variable but enhanced release, indicative of increased sympathetic activity, invariably was found during isometric exercise. The latter was associated with renal vasoconstriction. Further studies, employing intrarenal infusions of either the alpha-1 antagonist doxazosin or the alpha-2 antagonist yohimbine in doses that do not produce systemic effects, demonstrate that adrenergic vasoconstriction both at rest and during isometric exercise is accomplished mainly through alpha-2 receptors. It may be that an alpha- adrenoceptor mediated vascular response also determines the efficacy of chronic beta-blockade.
在一系列研究中,我们评估了高血压患者的肾传出神经活动。去甲肾上腺素的净肾释放量,计算为肾脏去甲肾上腺素的动静脉梯度乘以血流量,被用作局部肾上腺素能活动的指标。在各种情况下,肾血流量通过氙洗脱法测定。静息时去甲肾上腺素释放量变化不定,但在等长运动期间总是发现释放增强,这表明交感神经活动增加。后者与肾血管收缩有关。进一步的研究采用肾内输注不会产生全身效应剂量的α-1拮抗剂多沙唑嗪或α-2拮抗剂育亨宾,结果表明,静息和等长运动时的肾上腺素能血管收缩主要通过α-2受体实现。可能是α-肾上腺素能受体介导的血管反应也决定了慢性β受体阻滞剂的疗效。